Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 11 , ISSUE 3 ( July-September, 2022 ) > List of Articles


The Rising Concern of the SARS-CoV-2 Omicron Subvariants and Their Hybrids

H. Shafeeq Ahmed

Citation Information : Ahmed HS. The Rising Concern of the SARS-CoV-2 Omicron Subvariants and Their Hybrids. Indian J Respir Care 2022; 11 (3):283-284.

DOI: 10.4103/ijrc.ijrc_72_22

License: CC BY-NC-SA 4.0

Published Online: 01-12-2022

Copyright Statement:  Copyright © 2022; Indian Journal of Respiratory Care.


  1. Meo SA, Meo AS, Al-Jassir FF, Klonoff DC. Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics. Eur Rev Med Pharmacol Sci 2021;25:8012-8.
  2. Statement on Omicron sublineage BA.2. Available from: https://www.
  3. [Last accessed on 2022 Apr 03].
  4. Chen J, Wei GW. Omicron BA.2 (B.1.1.529.2): High potential to becoming the next dominating variant. Res Sq 2022:s3-1362445.
  5. Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med 2022;386:1532-46.
  6. Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 2021;385:585-94.
  7. Andrews N, Tessier E, Stowe J, Gower C, Kirsebom F, Simmons R, et al. Duration of protection against mild and severe disease by COVID-19 vaccines. N Engl J Med 2022;386:340-50.
  8. Goutam Mukherjee A, Ramesh Wanjari U, Murali R, Chaudhary U, Renu K, Madhyastha H, et al. Omicron variant infection and the associated immunological scenario. Immunobiology 2022;227:152222.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.